Our Senior Team

Christopher (Chris) Baird

Christopher (Chris) Baird

Managing Director San Francisco

Biography

Christopher Baird is a Managing Director at Moelis & Company, where he specializes in advising clients across the Healthcare sector with a focus on life sciences, including pharmaceuticals and biotechnology companies. Chris has over 15 years of investment banking experience advising clients on a broad range of buyside and sellside transactions, including mergers and acquisitions, licensing and collaborations, capital raising solutions, as well as advising boards of directors and special committees.

Chris began his investment banking career at Leerink. He holds a B.Sc. in Economics from The Wharton School at the University of Pennsylvania.

T: +1 415 870 2809

Our Strategic Alliances

MA Moelis Australia

Moelis & Company provides investment banking advice in Australia through our strategic alliance with MA Moelis Australia, the Corporate Advisory and Equities division of MA Financial Group, an Australian Stock Exchange (ASX) listed firm. MA Moelis Australia provides financial advice for clients across M&A and strategic advisory, equity and debt capital markets, capital structure advisory, equities research and trading.

Learn more about MA Moelis Australia here.

Learn more about MA Financial Group here.

Alfaro, Dávila y Scherer, S.C.

Moelis & Company has a strategic alliance with Alfaro, Dávila y Scherer, S.C. (“ADS”), the leading independent strategic and financial advisory firm in Mexico, to provide advisory services to our global client base with a focus on Mexican cross-border transactions. Founded in 2003, ADS advises a select number of clients on strategic mergers, acquisitions, divestitures, capital raising and financial restructurings.

Learn more about ADS team here.